Wikidata

(Q65345404)

English

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

short name
SOPHIA (English)
0 references
title
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment (English)
0 references
country
Austria
0 references
Belgium
0 references
Canada
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Israel
0 references
Italy
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Spain
0 references
United Kingdom
0 references
start time
24 August 2015
0 references
end time
March 2020
0 references
number of participants
624
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65345404&oldid=1858177504"